SBIR/STTR Research Award

Novel technologies to remove obscuring blood from fine needle aspiration biopsies

Award identifier 0bbcb0c51e0868cdc724ce4ba5df7f70ca6c3d408143cbcc677200657abebb64Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$2,301,288

Program and phase

SBIR · Phase II

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
AFFINERGY, LLC
Proposal award date
2015-06-01
Contract end date
2020-05-31
UEI
YJQ6K1QMS488
Solicitation number
PA18-591
Topic code
NIGMS

Research abstract

SUMMARY ABSTRACT Fine needle aspirationFNAcytology is the standard technique for evaluating thyroid nodulesHemorrhaging is common during the procedurehoweverleading to an aspirate that is significantly diluted by bloodSubsequent slide preparations are often suboptimalresulting in nondiagnostic outcomes that necessitate additional testing or diagnostic surgeryIn factquality is so unpredictable that a pathologist must often be present in the operating room to certify that the slides are adequatethus adding substantial cost and complexity to the procedureAncillary testing such as immunocytochemistry and fluorescence in situ hybridization can also be used for evaluating the aspiratebut such tests are not usually carried out using smears due to a paucity of follicular cells and an abundance of red blood cellsAs a resultadditional slides must be prepared using expensive and time consuming techniquesThusthere is a significant need for increasing the capture and isolation of thyroid cells on FNA slide preparationsAffinergy is developing a novel technology for improving the quality of thyroid FNA slide preparationsWe have identified proprietary peptides that binds with high affinity to thyroid cells but not to red or white blood cellsand we have developed a cell specific coating for glass slides that provides a simplereproducible method for preparing optimal FNA slides from samples contaminated with bloodA reduction in non diagnostic results will lead to improved quality of care and fewer unnecessary tests and diagnostic surgeriesAt the conclusion of this Phase II projectwe will have sufficient data in hand to rapidly bring our peptide conjugated slides to market PROJECT NARRATIVE Thyroid fine needle aspiration cytology is challenging in aspirates contaminated by obscuring blood cellsoften leading to non diagnostic resultsA reduction in non diagnostic outcomes would lead to improved quality of care and a reduction in unnecessary proceduresIn this applicationwe will develop a novel method for reliably separating thyroid cells and blood cellsleading to higher quality slide preparations and fewer non diagnostic results

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

75 SBIR/STTR records share this UEI (2005–2023). Reported award amounts total $59,804,968. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.